{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:29:38Z","timestamp":1791217778202,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","award":["419760"],"award-info":[{"award-number":["419760"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2008139"],"award-info":[{"award-number":["2008139"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["20100019"],"award-info":[{"award-number":["20100019"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.ajpath.2012.06.003","type":"journal-article","created":{"date-parts":[[2012,7,15]],"date-time":"2012-07-15T22:17:45Z","timestamp":1342390665000},"page":"1099-1111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["The Alarmin IL-33 Is a Notch Target in Quiescent Endothelial Cells"],"prefix":"10.1016","volume":"181","author":[{"given":"Eirik","family":"Sundlis\u00e6ter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reidunn J.","family":"Edelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Hol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Sponheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel M.","family":"K\u00fcchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina A.","family":"Udalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim S.","family":"Midwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kasprzycka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guttorm","family":"Haraldsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2012.06.003_bib1","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2353\/ajpath.2008.080014","article-title":"Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation","volume":"173","author":"K\u00fcchler","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2012.06.003_bib2","doi-asserted-by":"crossref","first-page":"e3331","DOI":"10.1371\/journal.pone.0003331","article-title":"The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel \u2018alarmin\u2019?","volume":"3","author":"Moussion","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2012.06.003_bib3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.immuni.2009.05.007","article-title":"Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases","volume":"31","author":"L\u00fcthi","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.ajpath.2012.06.003_bib4","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1073\/pnas.0812690106","article-title":"The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1","volume":"106","author":"Cayrol","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2012.06.003_bib5","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.1074\/jbc.M111.298703","article-title":"Interleukin 33 as a mechanically responsive cytokine secreted by living cells","volume":"287","author":"Kakkar","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2012.06.003_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.it.2009.03.003","article-title":"Interleukin-33\u2013cytokine of dual function or novel alarmin?","volume":"30","author":"Haraldsen","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.ajpath.2012.06.003_bib7","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.4049\/jimmunol.1003080","article-title":"The dual function cytokine IL-33 interacts with the transcription factor NF-kappaB to dampen NF-kappaB-stimulated gene transcription","volume":"187","author":"Ali","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2012.06.003_bib8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.0606854104","article-title":"IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo","volume":"104","author":"Carriere","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2012.06.003_bib9","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/embor.2008.145","article-title":"Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket","volume":"9","author":"Roussel","year":"2008","journal-title":"EMBO Rep"},{"key":"10.1016\/j.ajpath.2012.06.003_bib10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.devcel.2009.01.015","article-title":"Angiogenesis: a team effort coordinated by notch","volume":"16","author":"Phng","year":"2009","journal-title":"Dev Cell"},{"key":"10.1016\/j.ajpath.2012.06.003_bib11","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1161\/01.RES.0000266408.42939.e4","article-title":"Notch signaling in blood vessels: who is talking to whom about what?","volume":"100","author":"Hofmann","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpath.2012.06.003_bib12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ceb.2010.08.010","article-title":"Dynamics of endothelial cell behavior in sprouting angiogenesis","volume":"22","author":"Eilken","year":"2010","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.ajpath.2012.06.003_bib13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrc2130","article-title":"The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth","volume":"7","author":"Thurston","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2012.06.003_bib14","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.1074\/jbc.M008506200","article-title":"The basic helix-loop-helix transcription factor HESR1 regulates endothelial cell tube formation","volume":"276","author":"Henderson","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2012.06.003_bib15","doi-asserted-by":"crossref","first-page":"8813","DOI":"10.1128\/MCB.24.20.8813-8822.2004","article-title":"Notch activation induces endothelial cell cycle arrest and participates in contact inhibition: role of p21Cip1 repression","volume":"24","author":"Noseda","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2012.06.003_bib16","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1096\/fj.05-4880fje","article-title":"Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K\/Akt pathways and requires MAML1","volume":"20","author":"Liu","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2012.06.003_bib17","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/nature08878","article-title":"Therapeutic antibody targeting of individual Notch receptors","volume":"464","author":"Wu","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2012.06.003_bib18","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/nature05313","article-title":"Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis","volume":"444","author":"Ridgway","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2012.06.003_bib19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.mvr.2007.06.006","article-title":"Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells","volume":"75","author":"Harrington","year":"2008","journal-title":"Microvasc Res"},{"key":"10.1016\/j.ajpath.2012.06.003_bib20","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cell.2009.03.025","article-title":"The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis","volume":"137","author":"Benedito","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2012.06.003_bib21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2144\/000112401","article-title":"Isolation and solubilization of proteins after TRIzol extraction of RNA and DNA from patient material after prolonged storage","volume":"42","author":"Hummon","year":"2007","journal-title":"Biotechniques"},{"key":"10.1016\/j.ajpath.2012.06.003_bib22","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1093\/bioinformatics\/bti473","article-title":"MatInspector and beyond: promoter analysis based on transcription factor binding sites","volume":"21","author":"Cartharius","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ajpath.2012.06.003_bib23","doi-asserted-by":"crossref","first-page":"29967","DOI":"10.1074\/jbc.272.47.29967","article-title":"The cyclin-dependent kinase inhibitor p21cip1 mediates the growth inhibitory effect of phorbol esters in human venous endothelial cells","volume":"272","author":"Zezula","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2012.06.003_bib24","doi-asserted-by":"crossref","first-page":"8690","DOI":"10.1158\/0008-5472.CAN-05-1208","article-title":"Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function","volume":"65","author":"Patel","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2012.06.003_bib25","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1126\/science.1074560","article-title":"Oscillatory expression of the bHLH factor Hes1 regulated by a negative feedback loop","volume":"298","author":"Hirata","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2012.06.003_bib26","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature07083","article-title":"Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation","volume":"454","author":"Tammela","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2012.06.003_bib27","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1172\/JCI200317842","article-title":"Comparative genomic tools and databases: providing insights into the human genome","volume":"111","author":"Pennacchio","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2012.06.003_bib28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0002-9440(10)63631-0","article-title":"Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules","volume":"163","author":"Baekkevold","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2012.06.003_bib29","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1101\/gad.14.11.1313","article-title":"Dll4, a novel Notch ligand expressed in arterial endothelium","volume":"14","author":"Shutter","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.ajpath.2012.06.003_bib30","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nature05571","article-title":"Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis","volume":"445","author":"Hellstr\u00f6m","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2012.06.003_bib31","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature07039","article-title":"Wound repair and regeneration","volume":"453","author":"Gurtner","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2012.06.003_bib32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.gde.2010.10.008","article-title":"Vessel abnormalization: another hallmark of cancer?","volume":"21","author":"De Bock","year":"2010","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.ajpath.2012.06.003_bib33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/MCB.23.1.14-25.2003","article-title":"Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis","volume":"23","author":"Liu","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2012.06.003_bib34","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1182\/blood-2007-11-126045","article-title":"Dll4 activation of Notch signaling reduces tumor vascularity and inhibits tumor growth","volume":"112","author":"Segarra","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2012.06.003_bib35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature10908","article-title":"Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling","volume":"484","author":"Benedito","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2012.06.003_bib36","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1182\/blood-2006-12-063933","article-title":"Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion","volume":"109","author":"Scehnet","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2012.06.003_bib37","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1096\/fj.07-9998com","article-title":"RBP-J, the transcription factor downstream of Notch receptors, is essential for the maintenance of vascular homeostasis in adult mice","volume":"22","author":"Dou","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2012.06.003_bib38","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1038\/nature08751","article-title":"Chronic DLL4 blockade induces vascular neoplasms","volume":"463","author":"Yan","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2012.06.003_bib39","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/nature05355","article-title":"Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis","volume":"444","author":"Noguera-Troise","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2012.06.003_bib40","doi-asserted-by":"crossref","first-page":"40681","DOI":"10.1074\/jbc.M110.176065","article-title":"Feed-forward signaling by membrane-bound ligand receptor circuit: the case of Notch delta-like 4 ligand in endothelial cells","volume":"285","author":"Caolo","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2012.06.003_bib41","doi-asserted-by":"crossref","first-page":"8055","DOI":"10.1074\/jbc.M110.192641","article-title":"Angiopoietin-1\/Tie2 signal augments basal Notch signal controlling vascular quiescence by inducing delta-like 4 expression through AKT-mediated activation of {beta}-catenin","volume":"286","author":"Zhang","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2012.06.003_bib42","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.devcel.2008.12.009","article-title":"Nrarp coordinates endothelial Notch and Wnt signaling to control vessel density in angiogenesis","volume":"16","author":"Phng","year":"2009","journal-title":"Dev Cell"},{"key":"10.1016\/j.ajpath.2012.06.003_bib43","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.immuni.2008.10.006","article-title":"A Notch in the Toll belt","volume":"29","author":"Hertzog","year":"2008","journal-title":"Immunity"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944012004312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944012004312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:37:13Z","timestamp":1757601433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944012004312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0002944012004312"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2012.06.003","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Alarmin IL-33 Is a Notch Target in Quiescent Endothelial Cells","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2012.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}